Mary Chebib
Mary Chebib
Professor of Pharmaceutical Neuroscience, The University of Sydney
Verified email at - Homepage
Cited by
Cited by
The ‘ABC’of GABA receptors: a brief review
M Chebib, GAR Johnston
Clinical and experimental pharmacology and physiology 26 (11), 937-940, 1999
GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology
M Chebib, GAR Johnston
Journal of medicinal chemistry 43 (8), 1427-1447, 2000
Flavonoid modulation of GABAA receptors
JR Hanrahan, M Chebib, GAR Johnston
British journal of pharmacology 163 (2), 234-245, 2011
The dietary flavonoids apigenin and (−)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABAA receptors
EL Campbell, M Chebib, GAR Johnston
Biochemical pharmacology 68 (8), 1631-1638, 2004
Alpha9 nicotinic acetylcholine receptors and the treatment of pain
JM McIntosh, N Absalom, M Chebib, AB Elgoyhen, M Vincler
Biochemical pharmacology 78 (7), 693-702, 2009
Modulation of ionotropic GABA receptors by natural products of plant origin
GAR Johnston, JR Hanrahan, M Chebib, RK Duke, KN Mewett
Advances in pharmacology 54, 285-316, 2006
Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2
RJ Vandenberg, AD Mitrovic, M Chebib, VJ Balcar, GAR Johnston
Molecular Pharmacology 51 (5), 809-815, 1997
The β‐amyloid protein of Alzheimer’s disease binds to membrane lipids but does not bind to the α7 nicotinic acetylcholine receptor
DH Small, D Maksel, ML Kerr, J Ng, X Hou, C Chu, H Mehrani, S Unabia, ...
Journal of neurochemistry 101 (6), 1527-1538, 2007
GABAC receptors as drug targets
GAR Johnston, M Chebib, JR Hanrahan, KN Mewett
Current Drug Targets-CNS & Neurological Disorders 2 (4), 260-268, 2003
The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in mice
SP Fernandez, M Nguyen, TT Yow, C Chu, GAR Johnston, JR Hanrahan, ...
Neurochemical research 34 (10), 1867-1875, 2009
α4βδ GABAA receptors are high-affinity targets for γ-hydroxybutyric acid (GHB)
N Absalom, LF Eghorn, IS Villumsen, N Karim, T Bay, JV Olsen, ...
Proceedings of the National Academy of Sciences 109 (33), 13404-13409, 2012
M Chebib
Clinical and experimental pharmacology and physiology 31 (11), 800-804, 2004
Semisynthetic preparation of amentoflavone: a negative modulator at GABAA receptors
JR Hanrahan, M Chebib, NLM Davucheron, BJ Hall, GAR Johnston
Bioorganic & medicinal chemistry letters 13 (14), 2281-2284, 2003
Novel, potent, and selective GABAC antagonists inhibit myopia development and facilitate learning and memory
M Chebib, T Hinton, KL Schmid, D Brinkworth, H Qian, S Matos, HL Kim, ...
Journal of Pharmacology and Experimental Therapeutics 328 (2), 448-457, 2009
The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors
T Bakas, PS Van Nieuwenhuijzen, SO Devenish, IS McGregor, JC Arnold, ...
Pharmacological research 119, 358-370, 2017
Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant α1β2γ2L GABAA receptors
SH Huang, RK Duke, M Chebib, K Sasaki, K Wada, GAR Johnston
European journal of pharmacology 464 (1), 1-8, 2003
GABAA receptors and the diversity in their structure and pharmacology
HC Chua, M Chebib
Advances in Pharmacology 79, 1-34, 2017
GABAC receptor antagonists differentiate between human ρ1 and ρ2 receptors expressed in Xenopus oocytes
M Chebib, KN Mewett, GAR Johnston
European journal of pharmacology 357 (2-3), 227-234, 1998
Structure and activity of (2, 8)-dicarba-(3, 12)-cystino α-ImI, an α-conotoxin containing a nonreducible cystine analogue
CA MacRaild, J Illesinghe, BJ Lierop, AL Townsend, M Chebib, BG Livett, ...
Journal of medicinal chemistry 52 (3), 755-762, 2009
Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant α1β2γ2L GABAA receptors
SH Huang, RK Duke, M Chebib, K Sasaki, K Wada, GAR Johnston
European journal of pharmacology 494 (2-3), 131-138, 2004
The system can't perform the operation now. Try again later.
Articles 1–20